Chemours (CC) Tops Q4 EPS by 14c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
The Chemours Company Reports Fourth Quarter and Full Year 2019 Results
February 13, 2020 4:15 PM ESTWILMINGTON, Del., Feb. 13, 2020 /PRNewswire/ --
Full Year 2019 Results
Net Sales of $5.5 billion Net Income of $(52) million with EPS of $(0.32)Â Adjusted Net Income of $419 million with Adjusted EPS of $2.51 Adjusted EBITDA of $1.02 billion Free Cash Flow of $169 million Returned $486 million to shareholders through share repurchases and dividendsFourth Quarter 2019 Results
Net Sales of $1.4 billion Net Income of $(317) million with EPS of $(1.94) Â Adjusted Net Income of $92 million, with Adjusted EPS of $0.56 Adjusted EBITDA of $227 million Free... More